skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,155) Views

Editor in Chief Dr Roger M Pinder

1176-6328


Marked effect of milnacipran combined with olanzapine for a delusional depressive patient
Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Tetsuo Shimizu
Neuropsychiatric Disease and Treatment 2005, 1:373-374
18 February 2005


Erratum: Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect ||Reprinted from Neuropsychiatric Disease and Treatment 2005, 1(3) 253–260||
Charlotte Wiker, Love Linnér, Marie-Louise Wadenberg, Torgny H Svensson
Neuropsychiatric Disease and Treatment 2005, 1:365-372
11 May 2005


An open label study of the use of EEG biofeedback using beta training to reduce anxiety for patients with cardiac events
Anne John Michael, Saroja Krishnaswamy, Jamaludin Mohamed
Neuropsychiatric Disease and Treatment 2005, 1:357-363
18 February 2005


Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia
W Dale Horst, Michael W Klein, Denise Williams, Steven F Werder
Neuropsychiatric Disease and Treatment 2005, 1:349-355
18 February 2005


Duration of untreated illness in panic disorder: a poor outcome risk factor?
A Carlo Altamura, Annalisa Santini, Daniele Salvadori, Emanuela Mundo
Neuropsychiatric Disease and Treatment 2005, 1:345-347
18 February 2005


The history of barbiturates a century after their clinical introduction
Francisco López-Muñoz, Ronaldo Ucha-Udabe, Cecilio Alamo
Neuropsychiatric Disease and Treatment 2005, 1:329-343
18 February 2005


Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment
David B Arciniegas, C Alan Anderson, Jeannie Topkoff, Thomas W McAllister
Neuropsychiatric Disease and Treatment 2005, 1:311-327
18 February 2005


Combination/augmentation strategies for improving the treatment of depression
Chantal Moret
Neuropsychiatric Disease and Treatment 2005, 1:301-309
18 February 2005


Fluvoxamine in the treatment of anxiety disorders
Jane Irons
Neuropsychiatric Disease and Treatment 2005, 1:289-299
18 February 2005


Opinion - Fluvoxamine
C Lindsay DeVane
Neuropsychiatric Disease and Treatment 2005, 1:287-287
28 February 2005


Editorial: Neurology and psychiatry: “Oh, East is East and West is West …” || FREE PAPER ||
Johan A Aarli
Neuropsychiatric Disease and Treatment 2005, 1:285-286
11 May 2005